Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1972
Source ID: NCT00742976
Associated Drug: Insulin Detemir; Insulin Insulatard
Title: Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients
Acronym: Le-Na
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Type 2|Weight Gain
Interventions: DRUG: Insulin Detemir; Insulin Insulatard|DRUG: Insulin Detemir, Insulin Insulatard
Outcome Measures: Primary: change in weight; change in extracellular volume, 17 weeks | Secondary: sodium excretion in urine, 24 hour blood pressure, body composition change,urine osmolality, urine albumin excretion, GFR, HbA1c, Blood lipid profile, NT-proBNP, plasma Albumin, Plasma metanephrines, aldosterone, active renin, angiotensin II, 17 weeks
Sponsor/Collaborators: Sponsor: Rigshospitalet, Denmark
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 24
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Start Date: 2008-06
Completion Date: 2009-12
Results First Posted:
Last Update Posted: 2010-01-20
Locations: Dept of Endocrinology, Rigshospitalet, Copenhagen, København Ø, DK_2100, Denmark
URL: https://clinicaltrials.gov/show/NCT00742976